World Drug Safety Congress Europe 2019 - 10 and 11 September - Amsterdam
September 10 - 11, 2019 - Amsterdam NLTerrapinn
tayyab.abbasi@terrapinn.com
Phone:+44 (0)207 092 1210
Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions. WORLD DRUG SAFETY FOCUSES ON: How to plan for the wider international drug safety landscape How to work compliantly with a global regulatory overview and recent developments How to establish a robust approach to safety in oncology and advanced therapies How to harness Big Data and emerging technologies such as AI to support your safety measures How to manage drug safety operations in light of increasing complexities How to manage data and electronic submissions better How to effectively process the volume of cases How to operate within financial and logistical constraints All companies in the pharma industry have an enormous opportunity to better their drug safety capabilities, technological functions and risk management measures. It is core to ensuring regulatory compliance and establishing a robust PV strategy. It is core to your professional future.